Loading...

Eculizumab for Dense Deposit Disease and C3 Glomerulonephritis

BACKGROUND AND OBJECTIVES: The principle defect in dense deposit disease and C3 glomerulonephritis is hyperactivity of the alternative complement pathway. Eculizumab, a monoclonal antibody that binds to C5 to prevent formation of the membrane attack complex, may prove beneficial. DESIGN, SETTING, PA...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Bomback, Andrew S., Smith, Richard J., Barile, Gaetano R., Zhang, Yuzhou, Heher, Eliot C., Herlitz, Leal, Stokes, M. Barry, Markowitz, Glen S., D’Agati, Vivette D., Canetta, Pietro A., Radhakrishnan, Jai, Appel, Gerald B.
Format: Artigo
Sprog:Inglês
Udgivet: American Society of Nephrology 2012
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3338285/
https://ncbi.nlm.nih.gov/pubmed/22403278
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2215/CJN.12901211
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!